Correlation Between Madrigal Pharmaceuticals and Qualigen Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and Qualigen Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and Qualigen Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and Qualigen Therapeutics, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and Qualigen Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of Qualigen Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and Qualigen Therapeutics.

Diversification Opportunities for Madrigal Pharmaceuticals and Qualigen Therapeutics

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between Madrigal and Qualigen is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and Qualigen Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Qualigen Therapeutics and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with Qualigen Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Qualigen Therapeutics has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and Qualigen Therapeutics go up and down completely randomly.

Pair Corralation between Madrigal Pharmaceuticals and Qualigen Therapeutics

Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 0.5 times more return on investment than Qualigen Therapeutics. However, Madrigal Pharmaceuticals is 2.01 times less risky than Qualigen Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Qualigen Therapeutics is currently generating about -0.05 per unit of risk. If you would invest  28,876  in Madrigal Pharmaceuticals on November 9, 2024 and sell it today you would earn a total of  4,151  from holding Madrigal Pharmaceuticals or generate 14.38% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Madrigal Pharmaceuticals  vs.  Qualigen Therapeutics

 Performance 
       Timeline  
Madrigal Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Madrigal Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent technical and fundamental indicators, Madrigal Pharmaceuticals is not utilizing all of its potentials. The newest stock price mess, may contribute to short-term losses for the institutional investors.
Qualigen Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Qualigen Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Madrigal Pharmaceuticals and Qualigen Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Madrigal Pharmaceuticals and Qualigen Therapeutics

The main advantage of trading using opposite Madrigal Pharmaceuticals and Qualigen Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, Qualigen Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qualigen Therapeutics will offset losses from the drop in Qualigen Therapeutics' long position.
The idea behind Madrigal Pharmaceuticals and Qualigen Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.